<DOC>
	<DOC>NCT00878020</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety profile, tolerability, and pharmacokinetics of single oral doses from 10 mg up to 1200 mg of BMS-830216 (pro-drug of BMS-819881) in healthy subjects</brief_summary>
	<brief_title>Safety Study to Evaluate BMS-830216 in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male and female subjects as determined by medical history, physical examination, 12lead electrocardiogram (ECG), and clinical laboratory evaluations will be eligible to participate in the study Women who are not of childbearing potential (i.e., who are postmenopausal or surgically sterile) and men between ages of 18 to 45 Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECG or clinical laboratory determinations</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>